SHPMY News and Press, Shanghai Pharmaceuticals Holding Co Ltd ADR Repstg Shs H

2024-07-18 09:50:00 ET More on Shanghai Pharmaceuticals Holding Co., Ltd Historical earnings data for Shanghai Pharmaceuticals Holding Co., Ltd Dividend scorecard for Shanghai Pharmaceuticals Holding Co., Ltd Financial information for Shanghai Pharmaceuticals Holding...

2023-09-17 08:35:00 ET Summary Shanghai Hasten Biopharma has entered a $325 million agreement for greater China rights to a PCSK9 inhibitor from LIB Therapeutics. Insilico Medicine has out-licensed global rights to a small molecule inhibitor to Exelixis for BRCA-mutated tumors. ...

Summary Sichuan Kelun-Biotech will partner seven preclinical antibody-drug conjugate assets with Merck in a deal that pays Kelun-Biotech $175 million upfront and up to $9.3 billion in milestones - the third ADC deal between the two companies this year. LianBio announced that Pfizer will...

LianBio Launches to Bring US Assets to China; Announces $719 Million of In-Licensings Perceptive Advisors is launching LianBio to bring US biopharma assets to China. A successful fund operator, Perceptive has made investments in 150 public and 80 private biopharmas and has strong connectio...

SHENZHEN and SHANGHAI , August 6, 2020 /PRNewswire/ -- ImmVira Group Company and Shanghai Pharmaceuticals Holding Co., Ltd today announced a clinical collaboration and exclusive license agreement for ImmVira's MVR-T3011 intratumoral oncolytic virus program for the commercialization of n...

SHANGHAI , Sept. 30, 2019 /PRNewswire/ -- Shanghai Pharmaceuticals Holding Co., Ltd. (Shanghai Pharma)  (Hong Kong Stock Exchange: 2607) (Shanghai Stock Exchange: 601607) has launched a new stock incentive plan (the Plan) aligned with international standards aimed at retaining an...

SHANGHAI , April 15, 2019 /PRNewswire/ -- Shanghai Pharmaceuticals Holdings Co . Ltd.  (Shanghai Pharma or "the Company") (601607.SH ) ( 2067.HK), a major Chinese pharmaceutical group, has unveiled stock option incentive plans in a milestone move designed to accelerate restructuring ...